Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Cook Group Incorporated
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Branch vessel obstruction/compromise
Peri-aortic effusion/hematoma
Resistant hypertension
Persistent pain/symptoms
Transaortic growth \>5 mm within 3 months
Transaortic diameter \>40 mm.
You may not be if
Age \<18 years;
Other medical condition (e.g., cancer, congestive heart failure) that may cause the patient to be non-compliant with the protocol, confound the results, or is associated with limited life expectancy (i.e., less than 2 years)
Pregnant, breast-feeding, or planning on becoming pregnant within 24 months;
Unwilling or unable to comply with the follow-up schedule
Inability or refusal to give informed consent
Simultaneously participating in another investigative device or drug study. (The patient must have completed the primary endpoint of any previous study at least 30 days prior to enrollment in this study.)
Additional medical restrictions as specified in the Clinical Investigation Plan, or
Additional anatomical restrictions as specified in the Clinical Investigation Plan.
Clareo Health | Zenith® Dissection Endovascular System
